This presentation contains forward-looking statements about the company's plans, objectives, and future performance. Forward-looking statements include statements about expectations, projections, or predictions of future events and involve risks and uncertainties. The company may not achieve what is stated in the forward-looking statements. The presentation also discusses the company's market opportunity in healthcare communication technology, recent platform wins that validate its strategy, compelling return on investment demonstrated for customers, and third quarter 2016 financial highlights showing revenue growth and expanding profitability.

1. January 2017
Investor Review

2. This presentation contains forward-looking statements reflecting our current expectations that involve risks and uncertainties which are
subject to safe harbors under the Securities Act of 1933, as amended, or the Securities Act, and the Securities Exchange Act of 1934, as
amended, or the Exchange Act.
These forward-looking statements may include, but are not limited to, statements concerning our plans, objectives, expectations and
intentions, future financial position, future revenues, projected costs, expectations regarding demand and acceptance for our
technologies, growth opportunities and trends in the market in which we operate, prospects and plans and objectives of management.
The words “anticipates,” “believes,” “estimates," “expects,” “intends,” “may,” “plans,” “projects,” “will,” “would” and similar expressions
are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. We
may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place
undue reliance on our forward-looking statements.
These forward-looking statements involve risks and uncertainties that could cause our actual results to differ materially from those in
the forward-looking statements, including, without limitation, the risks set forth in Part II, Item 1A, “Risk Factors” in our Quarterly
Reports on Form 10-Q and in our other filings with the Securities and Exchange Commission. We do not assume any obligation to
update any forward-looking statements.
2
Forward-Looking Statements

3. 3
• Large market shifting towards Vocera
• Market leader with compelling ROI
• Large wins validate sales strategy
• Software acquisition extends platform
• Accelerating toward target financial model
*Earnings before interest, taxes, depreciation and amortization, and further excludes
stock -based compensation and change in fair value of warrant and option liabilities.
**Represents the high end of the company’s guidance range
$95 M
$104 M
$128M
-13%
-3%
3%
FY14 FY15 FY16 Guide- High**
Revenue A-EBITDA %*
Significant Value Creating Opportunity

4. (1) Joint Commission, an independent healthcare accreditation organization
(2) Agarwal et. al. Univ. of Maryland, 2010
92% of physicians use unsecured SMS text for
patient care, leading to data breeches and HIPAA
violations resulting in over $1.5M in fines per year
Efficient communication is a primary component
in driving patient engagement and satisfaction
Nurses often only spend 20% of their time
delivering direct care at the patient bedside
69% of accidental deaths and serious injuries in
hospitals are caused by communications breakdowns1
Cybercriminals
are increasingly going after targets in
the medical and healthcare verticals
$12 billion
wasted annually
In U.S. hospitals as a result of
communication inefficiencies2
4
Healthcare Communication Challenges

5. Market Forces Vocera Forces
5
Political Forces
Sales & Marketing
Product
Technology Forces
Device of Choice
CC&C
Unified Platform
ROI Selling
Cross Selling
System-level Deals
Meaningful Use Hangover
ACA Repeal
Medicare/Medicaid
Hospital Budgets
Scalability
Integration
Unified Platform
Strong Backlog/Def
Revenue
Approaching Target
model
2017 Context

6. Vocera Before Vocera Now
Communications
Badge-Centric
Point Product
Department Sale
Clinical Workflow
Software-Centric
Complete Solution
Enterprise Sale
Strategic Evolution

7. • Large System Deals
• Further penetrate existing
health system customers
• Continue pace of new
customer acquisition
Building momentum
across new products
• EHR Integration
• Collaboration Suite
• Clinical Integration
• Even Driven Alerts
• Care Experience
Extend Reach to
New Users
• Physicians
• Long Term Care
• Surgery Centers
Attractive International
Markets
• Canada
• United Kingdom
• Saudi Arabia
• UAE
• Qatar
• Australia
• Singapore
• Malaysia
Core Customer
Growth
Software
New Users
International
Expansion
7
Our Opportunity: Multiple Avenues for Growth

8. Quality ExperiencePatient-CenteredCost
Enhance how care is
provided to help
patients to achieve
better outcomes
Increase
Operational
Efficiencies
Improve patient
experience by allowing
caregivers to be
Patient Centered
Improve the caregiver
experience by improving
workflow and empowering
care teams
The Quadruple Aim
8
Our Mission

9. By enabling the care team to get the data, context, presence, and insights needed to…
Achieve the Quadruple Aim
Focus on the Patient Enhance workflows Make information
and help easier to find
9
How Do We Do That?

10. 10
Communicate Engage
Experience
Improve response
times, patient care,
safety and satisfaction
Over 120 clinical
integrations
Secure Text,
Voice, Image
Clinical Communication and Collaboration

11. 11
Hospital Staff Physicians Post Acute Home
Badge MC40-HC iPhone Android Tablets Desktop
Voice Secure Texting Clinical Integration
and Workflow
Patient Engagement
Vocera Software Platform
Communication and Clinical Workflows
Master Directory with Care Team Sync
Staff Assignment and On-Call Scheduling
Analytics and Reporting
Certified Security
Clinical System Integrations
Enterprise-Grade Communication Platform

12. Vocera’s Clinical Integrations
EHR Nurse
Call
Physiologic
Monitoring
Patient
Management
RTLS Fall
Prevention
Enhance
Patient Safety
Increase
Patient Satisfaction
Improve
Team Efficiency
Decrease
Length of Stay
Platform integration delivers critical alerts to the right user, with the right
information, at the right time and place, on their device of choice
Patient SatisfactionCare Team Efficiency
12
Integrated with 120+ Clinical Systems

13. 13
The Device of Choice Differentiator

14. Key Differentiators:
• Enterprise-class platform
(vs cobbling together vendors)
• Clinical Integration
• Device of Choice (Apple and Zebra)
• Vocera Badge resonates with nursing
• Superb References
• World-Class Support
and Professional Services
(1) Joint Commission, an independent healthcare accreditation organization
(2) Agarwal et. al. Univ. of Maryland, 2010 14
MEDCOM
Healthcare Recent Platform Wins Validate Strategy

15. 15
Scalable, Secure and Integrated = we consistently win >70% of competitive sales
StatusQuo
• Pagers
• Overhead Paging
• Shouting or Walking
Wireless
Devices
• Spectralink
• Cisco
• Ascom
Smartphone
Apps
• Voalte
• Tiger Text
• Texting Solutions
• Mobile Apps
 Complete end-to-end solution
 Role-based intelligence
 Device of Choice
 Ease-of-use
 Hands-free
 Clinical integration
 Enterprise class
 Trusted provider
 Purpose-built device
 World class service and support
Competitive Landscape

16. 16
10 minutes
per nurse per shift
Bed turnover
rates up 50%
OR revenues
up $780,000
350 more annual
OR capacity hours
4,000 annual ED
hours recaptured
Operational Efficiency
Response times down
from 2 minutes to
9 seconds
35% overall Sat Rating
improvement
25% improvement
in HCAHPS scores
Fall related injuries
down 60%; estimated
$1.27 mm savings
Patient Safety and Satisfaction
Compelling Return on Investment

17. 17
• 60% revenues
are recurring
• High visibility
• Low customer
concentration
% of 2015
Revenue Revenue Streams
• Perpetual licenses
• Subscriptions
Software
*20% recurring
15%
• Software maintenance
• Technical support
Maintenance
*All recurring
37%
• Professional services
• Deployment & training
Services9%
39% Devices
*50% recurring
• Badges
• Batteries, chargers, accessories
Diversified Revenue Streams

18. (1) Earnings before interest, taxes, depreciation and amortization, and further
excludes stock -based compensation and change in fair value of warrant and option liabilities.
Revenue Q3 2016 Highlights
Adjusted EBITDA
$26.5 $33.8
$75.7
$91.7
Q3 15 Q3 16 YTD 15 YTD 16
($inMillions)
-$0.4
$2.6
-$3.0
$3.3
Q315 Q316 YTD 15 YTD 16
($inMillions)
Q3 Results exceeded expectations
• 28% Revenue Growth
• Software up 32% YTD 2016
• Record Q3 Backlog, and Deferred Revenue;
balanced growth
Solid Customer Base and Value Proposition
• 95%+ s/w maintenance renewal rate
• Strong competitive win rate
Expanding Profitability and Cash Flow
• A-EBITDA $2.6 million
• Positive operating cash flow
18
+28% +21%
Q3’16 & YTD Financial Highlights

19. 19
Actual
2014 2015 Q1-Q3 ‘16
R&D % of Revenue 17.2% 15.3% 13%
S&M % of Revenue 47.4% 41.3% 38%
G&A % of Revenue 12.8% 11.8% 11%
~$200M
Target Model
12%
29%
8%
Sales
Notes
• All numbers are non-GAAP
• Mean peer group enterprise value comps are 3-4x Revenue and 12-15x A-EBITDA
Drivers
Operating Leverage Drives Significant Value

20. Thank you!